Robert Libke

777 total citations
23 papers, 609 citations indexed

About

Robert Libke is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Robert Libke has authored 23 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in Robert Libke's work include Fungal Infections and Studies (13 papers), Antifungal resistance and susceptibility (11 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Robert Libke is often cited by papers focused on Fungal Infections and Studies (13 papers), Antifungal resistance and susceptibility (11 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Robert Libke collaborates with scholars based in United States and Switzerland. Robert Libke's co-authors include J. T. Clarke, William Kirby, C Regamey, R Lüthy, Edward D. Ralph, William Kirby, Michael W. Peterson, Jose Joseph, Marilyn A. Mitchell and Michael MacLean and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Bone and Joint Surgery.

In The Last Decade

Robert Libke

22 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Libke United States 13 309 285 204 98 65 23 609
Jerome Santoro United States 12 186 0.6× 161 0.6× 198 1.0× 73 0.7× 51 0.8× 25 485
M. Micoud France 14 205 0.7× 271 1.0× 96 0.5× 68 0.7× 42 0.6× 70 739
J. A. Faiella United States 8 146 0.5× 227 0.8× 208 1.0× 161 1.6× 41 0.6× 8 529
A Contrepois France 16 385 1.2× 424 1.5× 278 1.4× 110 1.1× 33 0.5× 32 804
Conrad J. Wilkowske United States 14 192 0.6× 309 1.1× 87 0.4× 77 0.8× 83 1.3× 33 569
M S Simberkoff United States 8 209 0.7× 282 1.0× 123 0.6× 60 0.6× 21 0.3× 8 470
Jacques Dubois Canada 13 91 0.3× 225 0.8× 119 0.6× 127 1.3× 37 0.6× 27 447
P. Van der Auwera Belgium 15 209 0.7× 260 0.9× 260 1.3× 151 1.5× 48 0.7× 41 713
Jiso Ryu South Korea 10 152 0.5× 264 0.9× 122 0.6× 312 3.2× 56 0.9× 20 608
G. K. Daikos Greece 16 140 0.5× 209 0.7× 252 1.2× 175 1.8× 79 1.2× 63 648

Countries citing papers authored by Robert Libke

Since Specialization
Citations

This map shows the geographic impact of Robert Libke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Libke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Libke more than expected).

Fields of papers citing papers by Robert Libke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Libke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Libke. The network helps show where Robert Libke may publish in the future.

Co-authorship network of co-authors of Robert Libke

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Libke. A scholar is included among the top collaborators of Robert Libke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Libke. Robert Libke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fayed, Mohamed, et al.. (2024). Overview of the Current Challenges in Pulmonary Coccidioidomycosis. Journal of Fungi. 10(10). 724–724. 3 indexed citations
2.
Libke, Robert, et al.. (2023). Challenges in the Long-term Management of Patients With Coccidioidal Meningitis: A Retrospective Analysis of Treatment and Outcomes. Open Forum Infectious Diseases. 10(6). ofad243–ofad243. 7 indexed citations
3.
Libke, Robert, et al.. (2021). COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021. Journal of Fungi. 7(11). 948–948. 4 indexed citations
4.
Libke, Robert, et al.. (2020). Disseminated Coccidioidomycosis with Clinically Evident Splenomegaly in an Immunocompetent Host, First Case Reported in the literature. McGill Journal of Medicine. 12(2). 14–14. 2 indexed citations
5.
Wilson, Leslie, Jie Ting, Michael MacLean, et al.. (2019). The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California. International Journal of Environmental Research and Public Health. 16(7). 1113–1113. 50 indexed citations
6.
Mitchell, Marilyn A., et al.. (2015). Development of a Real-Time PCR Assay for Identification of Coccidioides immitis by Use of the BD Max System. Journal of Clinical Microbiology. 53(3). 926–929. 26 indexed citations
7.
Paul, Stéphane, et al.. (2013). Cutaneous tuberculosis of the penis in an HIV-infected adult. International Journal of STD & AIDS. 24(1). 57–58. 7 indexed citations
8.
Thompson, George R., Shobha Sharma, Derek J. Bays, et al.. (2013). Coccidioidomycosis. CHEST Journal. 143(3). 776–781. 22 indexed citations
9.
Libke, Robert, et al.. (2009). Disseminated Coccidioidomycosis with ClinicallyEvident Splenomegaly in an ImmunocompetentHost, First Case Reported in the literature. SHILAP Revista de lepidopterología. 12(2). 1 indexed citations
10.
Libke, Robert, et al.. (2008). Pleural effusion in hospitalized patients with Coccidioidomycosis. Respiratory Medicine. 102(4). 537–540. 26 indexed citations
11.
Libke, Robert, et al.. (2008). Immune Reconstitution Inflammatory Syndrome Presenting as Superior Vena Cava Syndrome Secondary to Coccidioides Lymphadenopathy in an HIV-Infected Patient. Journal of the International Association of Physicians in AIDS Care. 7(6). 283–285. 12 indexed citations
12.
Tucker, Richard, John N. Galgiani, David W. Denning, et al.. (1990). Treatment of Coccidioidal Meningitis with Fluconazole. Clinical Infectious Diseases. 12(Supplement_3). S380–S389. 64 indexed citations
13.
Kirby, William, J. T. Clarke, Robert Libke, & C Regamey. (1976). Clinical Pharmacology of Amikacin and Kanamycin. The Journal of Infectious Diseases. 134(Supplement 2). S312–S315. 47 indexed citations
14.
Regamey, C, et al.. (1975). Inactivation of Cefazolin, Cephaloridine, and Cephalothin by Methicillin-Sensitive and Methicillin-Resistant Strains of Staphylococcus aureus. The Journal of Infectious Diseases. 131(3). 291–294. 39 indexed citations
15.
Libke, Robert, J. T. Clarke, Edward D. Ralph, R Lüthy, & William Kirby. (1975). Ticarcillin vs carbenicillin: Clinical pharmacokinetics. Clinical Pharmacology & Therapeutics. 17(4). 441–446. 34 indexed citations
16.
Ralph, Edward D., J. T. Clarke, Robert Libke, R Lüthy, & William Kirby. (1974). Pharmacokinetics of Metronidazole as Determined by Bioassay. Antimicrobial Agents and Chemotherapy. 6(6). 691–696. 91 indexed citations
17.
Regamey, C, Robert Libke, J. T. Clarke, & William Kirby. (1974). Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Infection. 2(3). 132–136. 10 indexed citations
18.
Clarke, J. T., Robert Libke, Edward D. Ralph, R Lüthy, & William Kirby. (1974). Human Pharmacokinetics of BL-P1654 Compared with Ampicillin. Antimicrobial Agents and Chemotherapy. 6(6). 729–733. 3 indexed citations
19.
Clarke, J. T., Robert Libke, C Regamey, & William Kirby. (1974). Comparative pharmacokinetics of amikacin and kanamycin. Clinical Pharmacology & Therapeutics. 15(6). 610–616. 99 indexed citations
20.
Libke, Robert, C Regamey, J. T. Clarke, & William Kirby. (1973). Synergism of Carbenicillin and Gentamicin Against Enterococci. Antimicrobial Agents and Chemotherapy. 4(5). 564–568. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerome Santoro Breakdown of academic impact, for papers by M. Micoud Breakdown of academic impact, for papers by J. A. Faiella Breakdown of academic impact, for papers by A Contrepois Breakdown of academic impact, for papers by Conrad J. Wilkowske Breakdown of academic impact, for papers by M S Simberkoff Breakdown of academic impact, for papers by Jacques Dubois Breakdown of academic impact, for papers by P. Van der Auwera Breakdown of academic impact, for papers by Jiso Ryu Breakdown of academic impact, for papers by G. K. Daikos
Rankless by CCL
2026